HOME
 
Piracetam
 
CDP choline
 
Vinpocetine
 
Idebenone
 
Galantamine
 
Modafinil
 
Deprenyl
 
Pyritinol
 
to Order
 
 
 
 
 



































 




The role of nicotinic acid in pathogenesis and therapy of psoriasis and eczema in patients abusing alcohol  

A.L. Tischenko, S.N. Stetsyuk, L.D. Tishchenko, 
I.A. Yusupov, F.S. Khalaf, S.M. TraoreI

[Article in Russian]

Bulletin of dermatology and venerology  No.2 1998

Abstract

Fifty two patients with psoriasis (n=38) and eczema (n=14) abusing alcohol had significantly reduced blood nicotinic acid levels. Total nicotinic acid in these two groups of patients was only 270±3.2 and 385±12.8 mg% respectively compared with its normal value 620±4.6 mg%. Free and albumin-bound nicotinic acid levels were 183±1.6 and 87±1.0 mg% respectively in psoriatic patients and 301±10.7 and 84±2.1 mg% in patients with eczema compared with 310±2.3 and 310±4.6 mg% respectively in healthy subjects (n=37). The heavy drinkers had the most severe forms of either disease characterized by extensive rash, strong itching, desquamation, and moist skin.  Therapy of these conditions encountered great difficulty.  Preparations of pikamilon and vitamin B6 (pyridoxal phosphate) were used in combination with piracetam (Nootropil) to treat 28 patients with psoriasis, eczema, alcohol abuse.  Based on high therapeutic efficiency of these products bringing blood nicotinic acid levels to normal, they are recommended as choice agents for combined therapy of patients with psoriasis and eczema abusing alcohol. 

Galantamine | Vinpocetine | Idebenone 
  Pyritinol | CDP Choline | Deprenyl | Piracetam
 Home | Order
www.AlzheimersTreatments.com

 

 

Hit Counter